- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03168763
Effect of Physician Attire on Patients' Preference of Physician
Advanced Cancer Patients' Perception of Physician Compassion and Professionalism - A Randomized, Double Blind, Cross Over Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
If participant agrees to take part in this study, participant will be asked to complete 7 questionnaires. These questionnaires ask about participant's gender, date of birth, ethnicity, marital status, level of education, religion, and information about the disease and treatments participant received. Participant will also be asked about any symptoms participant may be having, how much trust participant has in the medical profession in general, how participant feels about the disease, any depression or anxiety participant may have, and participant's level of hopefulness. These questionnaires should take about 6 minutes to complete.
Participant will be shown 2 videos (each 3 minutes long) and then participant will complete questions about each video. Participant will be asked to rate the doctors participant saw on their professionalism and their compassion.
Caregivers will be required to leave the room or stay silent while the participant is watching the videos.
The total time to watch the videos and complete the second set of questionnaires should be about 7 minutes.
Finally, participant will be asked to complete 3 questionnaires about participant's overall preference for a doctor. These questionnaires will take about 5 minutes to complete.
Length of Study Participation:
Participation in this study is complete after participant answers the final questionnaires.
Overall, this study should take about 30 minutes to complete.
This is an investigational study.
Up to 108 participants will be enrolled in this study. All will take part at MD Anderson.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77030
- University of Texas MD Anderson Cancer Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Advanced cancer diagnosis (locally advanced, recurrent or metastatic disease).
- Patients presenting as follow-ups only at the outpatient Supportive Care Center.
- Age >/= 18 years-old
- English speaking
Exclusion Criteria:
- Altered cognition (as assessed routinely in the Supportive Care Clinic using the Memorial Delirium Assessment Scale (MDAS), with a score of >/= 7/30).
- Patients suffering from a severe psychiatric disorder or condition that would significantly interfere with study participation.
- Patients with hearing and/or visual impairments.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Video 1A
Questionnaires completed at baseline, after each video viewing, and at completion. Participants shown Video 1A or 1B, then shown Video 2A or 2B. |
Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
|
Experimental: Video 1B
Questionnaires completed at baseline, after each video viewing, and at completion. Participants shown Video 1A or 1B, then shown Video 2A or 2B. |
Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
|
Experimental: Video 2A
Questionnaires completed at baseline, after each video viewing, and at completion. Participants shown Video 1A or 1B, then shown Video 2A or 2B. |
Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
|
Experimental: Video 2B
Questionnaires completed at baseline, after each video viewing, and at completion. Participants shown Video 1A or 1B, then shown Video 2A or 2B. |
Participants shown Video 1A or 1B, then shown Video 2A or 2B.
Questionnaires completed at baseline, after each video viewing, and at completion.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant's Perception of Physician's Compassion
Time Frame: 1 day
|
Participant's rating of physician's compassion assessed by using a validated 5-item tool consisting of five 0-10 numerical rating scales assessing five dimensions: warm-cold, pleasant-unpleasant, compassionate- distant, sensitive- insensitive, and caring-uncaring. The sum of the five scales gives a final score representing physician's compassion on a scale of 0 to 50. |
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Participant's Perception of Physician's Professionalism
Time Frame: 1 day
|
Participant's rating of physician's professionalism assessed by using a validated 4-item tool assessing politeness, listening, explaining the condition and treatment to the patient and patient's involvement in treatment decisions. Participant rates from poor-1 to very good-5. The sum of these 4 items gives a final score representing physician's level of professionalism on a scale of 4 to 20. |
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ahsan Azhar, MD, M.D. Anderson Cancer Center
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016-0970
- NCI-2018-01195 (Registry Identifier: NCI CTRP)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Neoplasms of Independent (Primary) Multiple Sites
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterWithdrawnMalignant Neoplasms of Independent (Primary) Multiple Sites
-
M.D. Anderson Cancer CenterActive, not recruitingMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Malignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple Sites | Benign Neoplasms | In Situ NeoplasmsUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterCompletedMalignant Neoplasms of Independent (Primary) Multiple SitesUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLC; BioMed Valley Discoveries, IncActive, not recruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasms of Mesothelial... and other conditionsUnited States
-
M.D. Anderson Cancer CenterEisai Inc.WithdrawnAdvanced Cancer | Malignant Neoplasms of Female Genital Organs | Malignant Neoplasm of Breast | Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasms... and other conditions
-
M.D. Anderson Cancer CenterGateway for Cancer Research; James B. and Lois R. Archer Charitable FoundationRecruitingMalignant Neoplasms of Female Genital Organs | Malignant Neoplasms of Lip Oral Cavity and Pharynx | Melanoma and Other Malignant Neoplasms of Skin | Malignant Neoplasm of Bone and Articular Cartilage | Malignant Neoplasms of Independent (Primary) Multiple Sites | Malignant Neoplasm of Male... and other conditionsUnited States
Clinical Trials on Video
-
National Development and Research Institutes, Inc.UnknownHIV TestingUnited States
-
Medical College of WisconsinCompleted
-
Massachusetts General HospitalFoundation for Informed Medical Decision MakingCompleted
-
Massachusetts General HospitalNational Institute of Mental Health (NIMH)RecruitingDepression | Anxiety | Mobile Phone Use | Health Knowledge, Attitudes, Practice | StigmatizationUnited States
-
Northwestern UniversityCompletedAutism Spectrum Disorder | AutismUnited States
-
Wolfson Medical CenterNot yet recruitingInduction of Labor Affected Fetus / Newborn
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Singapore Institute of TechnologyCompletedHealthy IndividualsSingapore